We get the same question every single day Whats the catch? The answer is simple, there is no catch
This aligns closely with the approximately 15% average weight loss seen with injectable Wegovy in earlier phase 3 trials, although the studies were not head-to-head and involved different designs and populations
Historic precedents are no indication of future trends, as the COVID pandemic showed, but Katz argued it does not matter whether the next pandemic is caused by a coronavirus, influenza, or something elsea reduction in the number of overweight people will lead to fewer deaths
What good monitoring looks like Routine follow-up with your diabetes doctor Retinal monitoring based on your baseline eye disease severity Faster eye review if symptoms appear or worsen Coordination between endocrinology and ophthalmology if retinopathy is active For some patients, this may mean standard annual follow-up
As demonstrated in previous trials, including SUSTAIN 6 and PIONEER 6, consistent adherence over extended periods is essential for optimal therapeutic outcomes